TrialArthritis & rheumatology (Hoboken, N.J.)2021

Distinct Gene Expression Signatures Characterize Strong Clinical Responders Versus Nonresponders to Canakinumab in Children With Systemic Juvenile Idiopathic Arthritis.

Emely L Verweyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.